| Erin Angelina Cullen, RN | |
|
11 Whitehall Rd, Rochester, NH 03867-3297 | |
| (603) 335-3211 | |
| Not Available |
| Full Name | Erin Angelina Cullen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 11 Whitehall Rd, Rochester, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114560810 | NPI | - | NPPES |
| 3120937 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 059331-21 (New Hampshire) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 059331-23 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cornerstone Vna | 4981619988 | 3 |
News Archive
The EQUIGEN trial shows that switching to and between generic versions of lamotrigine does not affect the plasma levels achieved by patients with epilepsy.
Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.
PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.
› Verified 6 days ago
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
The EQUIGEN trial shows that switching to and between generic versions of lamotrigine does not affect the plasma levels achieved by patients with epilepsy.
Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.
PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.
› Verified 6 days ago
| Entity Name | Cornerstone Vna |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508829045 PECOS PAC ID: 4981619988 Enrollment ID: O20140905000193 |
News Archive
The EQUIGEN trial shows that switching to and between generic versions of lamotrigine does not affect the plasma levels achieved by patients with epilepsy.
Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.
PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Angelina Cullen, RN 11 Whitehall Rd, Rochester, NH 03867-3297 Ph: (603) 335-3211 | Erin Angelina Cullen, RN 11 Whitehall Rd, Rochester, NH 03867-3297 Ph: (603) 335-3211 |
News Archive
The EQUIGEN trial shows that switching to and between generic versions of lamotrigine does not affect the plasma levels achieved by patients with epilepsy.
Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia. The trial met its primary endpoint demonstrating that ITI-007 was safe and well-tolerated in patients with stabilized schizophrenia.
PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."
Three well-known psychiatric researchers from Harvard Medical School may have violated federal and educational institution regulations by failing to properly disclose drug industry payments and other conflicts of interest, according to an investigation report published last week by Sen. Chuck Grassley (R-Iowa) in the Congressional Record, the Wall Street Journal reports (Armstrong, Wall Street Journal, 6/9).
Centura Health and DaVita HealthCare Partners today unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas.
› Verified 6 days ago
Mrs. Kathleen White Maclean, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 245 Rochester Hill Rd, Rochester, NH 03867 Phone: 603-335-2401 | |
Mrs. Amanda M Mertens, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11 Whitehall Rd, Rochester, NH 03867 Phone: 603-332-5211 | |
Sara M Dion, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 245 Rochester Hill Rd Ste 1a, Rochester, NH 03867 Phone: 603-335-2401 | |
Alyssa Koelker, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11 Whitehall Rd, Rochester, NH 03867 Phone: 603-994-7600 | |
Ms. Nancy Strafford Hesko, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 180 Farmington Rd, Rochester, NH 03867 Phone: 603-335-4522 Fax: 603-335-8631 | |
Judith Ann Hallisey, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 163 Rochester Hill Rd, Rochester, NH 03867 Phone: 603-332-0238 | |
Janice L Parker, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11 Whitehall Rd, Frisbie Memorial Hospital, Rochester, NH 03867 Phone: 603-335-8463 Fax: 603-330-8919 |